I am expecting a debt component to that funding and only debt. We have played out the equity raising already. I’m assuming that is why it is taking time.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025